Ibrutinib for the treatment of relapsed/refractory mantle cell lymphoma: Extended 3.5-year follow up from a pooled analysis

Simon Rule, Martin Dreyling, Andre Goy, Georg Hess, Rebecca Auer, Brad Kahl, José Ángel Hernández-Rivas, Keqin Qi, Sanjay Deshpande, Lori Parisi, Michael Wang

Research output: Contribution to journalLetterpeer-review

114 Scopus citations
Original languageEnglish
Pages (from-to)e211-e214
Issue number5
StatePublished - Apr 30 2019

Cite this